Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193805-21-000583
Filing Date
2021-04-30
Accepted
2021-04-30 16:01:20
Documents
7
Period of Report
2021-06-18

Document Format Files

Seq Description Document Type Size
1 e620530_def14a-arct.htm DEF 14A 514661
2 GRAPHIC image_001.jpg GRAPHIC 4053
3 GRAPHIC image_002.jpg GRAPHIC 22026
4 GRAPHIC image_003.jpg GRAPHIC 19363
5 GRAPHIC image_004.jpg GRAPHIC 21767
6 GRAPHIC image_005.jpg GRAPHIC 1232
7 GRAPHIC image_006.jpg GRAPHIC 1096
  Complete submission text file 0001193805-21-000583.txt   612316
Mailing Address 10628 SCIENCE CENTER DRIVE SUITE 250 SAN DIEGO CA 92121
Business Address 10628 SCIENCE CENTER DRIVE SUITE 250 SAN DIEGO CA 92121 8589002660
Arcturus Therapeutics Holdings Inc. (Filer) CIK: 0001768224 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38942 | Film No.: 21877654
SIC: 2834 Pharmaceutical Preparations